Taysha Gene Therapies Growth Metrics (2022-2025) | TSHA

Growth Metrics Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -0.77M-0.55M-0.27M-0.46M-0.04M-0.09M-0.11M-0.05M-0.02M0.06M22.83M
EBITDA Margin Growth (3y) -0.83M-0.58M22.45M
EBITDA Margin (QoQ) -0.29M-0.21M0.18M-0.45M-0.06M0.06M-0.01M-0.03M-0.12M0.05M0.05M0.01M-0.04M22.82M
EBIT Margin Growth (1y) -0.77M-0.55M-0.27M-0.46M-0.04M-0.09M-0.11M-0.05M-0.02M0.06M22.83M
EBIT Margin Growth (3y) -0.83M-0.58M22.45M
EBIT Margin (QoQ) -0.29M-0.21M0.18M-0.45M-0.06M0.06M-0.01M-0.03M-0.12M0.05M0.05M0.01M-0.04M22.82M
EBT Margin Growth (1y) -0.79M-0.56M-0.28M-0.46M-0.03M-0.08M-0.10M-0.05M-0.02M0.05M20.71M
EBT Margin Growth (3y) -0.84M-0.58M20.33M
EBT Margin (QoQ) -0.29M-0.21M0.18M-0.46M-0.07M0.07M-0.01M-0.02M-0.11M0.05M0.04M0.00M-0.04M20.71M
Enterprise Value Growth (1y) -108.44%-103.25%-6.93%250.36%3,321.54%9,334.57%543.65%3.26%4.89%-25.68%134.14%
Enterprise Value Growth (3y) 41.83%30.61%141.16%
Enterprise Value (QoQ) -45.93%-48.31%25.66%-124.04%79.21%1,581.85%373.05%121.04%-40.40%3.28%-24.11%124.53%-57.77%225.40%
FCF Margin Growth (1y) -0.79M-0.63M-0.32M0.05M-0.01M-0.12M-0.08M-0.05M-0.04M0.09M16.28M
FCF Margin Growth (3y) -0.83M-0.66M15.88M
FCF Margin (QoQ) -0.18M-0.27M-0.38M0.04M-0.03M0.04M-0.01M-0.01M-0.14M0.08M0.03M-0.01M-0.01M16.27M
Interest Coverage Ratio Growth (1y) 83.69%63.85%53.22%44.90%-6,861.40%-4,757.79%-9,668.19%-3,876.23%-34.38%-99.49%-110.20%
Interest Coverage Ratio Growth (3y) -148.03%-227.22%-357.97%
Interest Coverage Ratio (QoQ) 39.21%47.42%-75.11%70.86%-34.74%31.97%-106.26%-3,582.03%5.97%-36.79%16.04%-24.44%-39.58%-44.14%
Net Margin Growth (1y) -0.79M-0.56M-0.49M-0.29M-0.03M-0.09M0.10M-0.23M-0.02M0.05M21.96M
Net Margin Growth (3y) -0.84M-0.59M21.58M
Net Margin (QoQ) -0.29M-0.21M0.18M-0.46M-0.07M-0.14M0.38M-0.20M-0.12M0.05M0.05M-620.00-0.04M21.96M
Operating Margin Growth (1y) -0.77M-0.55M-0.27M-0.46M-0.04M-0.09M-0.11M-0.05M-0.02M0.06M22.83M
Operating Margin Growth (3y) -0.83M-0.58M22.45M
Operating Margin (QoQ) -0.29M-0.21M0.18M-0.45M-0.06M0.06M-0.01M-0.03M-0.12M0.05M0.05M0.01M-0.04M22.82M
Return on Assets Growth (1y) 100.0069.0093.0039.00-10.00-6.005.0014.00
Return on Assets (QoQ) 23.00-18.0053.0042.00-8.006.00-1.00-7.00-5.0018.008.00
Return on Capital Employed Growth (1y) 241.00153.00237.00-318.00-14.00-5.0010.0020.00
Return on Capital Employed (QoQ) 72.00-74.00555.00-313.00-15.0010.000.00M-9.00-6.0025.0010.00
Return on Equity Growth (1y) 0.00M-0.00M-567.00-347.00467.00-7.0034.0042.00
Return on Equity (QoQ) 0.00M-0.00M-211.00-836.00450.0031.009.00-23.00-24.0072.0017.00
Return on Sales Growth (1y) -0.00M0.01M0.00M259.00-537.00-579.00-499.00-675.00
Return on Sales (QoQ) -0.01M0.01M0.00M602.00-79.00-19.00-245.00-194.00-121.0061.00-420.00